Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorDundar, Emine
dc.contributor.authorOlgun, Esra Gurlek
dc.contributor.authorIsiksoy, Serap
dc.contributor.authorKürkçüoğlu, Mine
dc.contributor.authorBaşer, K. Hüsnü Can
dc.contributor.authorBal, Cengiz
dc.date.accessioned2019-10-19T14:15:23Z
dc.date.available2019-10-19T14:15:23Z
dc.date.issued2008
dc.identifier.issn0940-2993
dc.identifier.urihttps://dx.doi.org/10.1016/j.etp.2007.11.009
dc.identifier.urihttps://hdl.handle.net/11421/12811
dc.descriptionWOS: 000255508800008en_US
dc.descriptionPubMed ID: 18222658en_US
dc.description.abstractThe aim of the present study is to investigate the treatment efficiency of intra-rectal (IR) and intra-peritoneal (W) application of Origanum onites essential oil (OOEO), which is a well-known antioxidant, in the colitis model induced by 2,4,6-trinitrobenzenesulfonic acid (TNBS) and ethanol (E) in comparison with dexamethasone therapy through the morphologic damage score. Monoclonal antibodies against intercellular adhesion molecule-1 (ICAM-1, CD54), antirat granulocytes, and myeloperoxidase (MPO), were also investigated immunohistochemically. There was a significant difference in terms of ulceration, mucus cell depletion, inflammatory cell infiltration, vascular dilatation (P < 0.001), crypt abscesses (p < 0.01), and edema (p < 0.05) between OOEO-1 mg/kg-IR and control colitis groups. A significant difference was encountered in terms of mucus cell depletion, crypt abscesses, inflammatory cell infiltration, vascular dilatation (p < 0.01), and ulceration (p < 0.05) between the OOEO-0.1 mg/kg-IR and control colitis groups. A significant difference was noticed in terms of ulceration, inflammatory cell infiltration, mucus cell depletion (P < 0.001), vascular dilatation (p < 0.01), and mucosal atrophy (p < 0.05) between the OOEO-1 mg/kg-IP and control colitis groups. There was a significant difference in terms of ulceration, mucus cell depletion, inflammatory cell infiltration (p < 0.001), crypt abscesses, vascular dilatation (p < 0.01), and mucosal atrophy (p < 0.05) between the OOEO-0.1 mg/kg-IP and control colitis groups. No significant difference was determined in terms of ulceration, inflammatory cyst, mucosal atrophy, edema, and vascular dilatation between the dexamethazone and control colitis groups (p > 0.05). Under the present conditions, we concluded that IR and IP OOEO treatment, applied at the dosage of 0.1 or 1 mg/kg/day, have a significant protective effect on the colonic injuryen_US
dc.language.isoengen_US
dc.publisherElsevier GMBH, Urban & Fischer Verlagen_US
dc.relation.isversionof10.1016/j.etp.2007.11.009en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectTreatment Of Inflammatory Bowel Diseaseen_US
dc.subjectOriganum Onitesen_US
dc.subject2, 4, 6-Trinitrobenzenesulfonic Acid-Induced Colitisen_US
dc.titleThe effects of intra-rectal and intra-peritoneal application of Origanum onites L. essential oil on 2,4,6-trinitrobenzenesulfonic acid-induced colitis in the raten_US
dc.typearticleen_US
dc.relation.journalExperimental and Toxicologic Pathologyen_US
dc.contributor.departmentAnadolu Üniversitesi, Eczacılık Fakültesi, Farmakognozi Anabilim Dalıen_US
dc.identifier.volume59en_US
dc.identifier.issue6en_US
dc.identifier.startpage399en_US
dc.identifier.endpage408en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.contributor.institutionauthorKürkçüoğlu, Mine
dc.contributor.institutionauthorBaşer, K. Hüsnü Can


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster